Borazanci, E. H., Rasco, D. W., Kasi, A., Sohal, D., Handler, J. S., Dayyani, F., Grieb, B., Zuniga, R. M., Garbo, L. E., Pashova, H. I., Choudhry, P., Pai, S. G., Chandana, S. R. (2026). TRIDENT: A phase 2 study of relacorilant plus nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic ductal adenocarcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps4263